PharmaShots Weekly Snapshots (June 06– 10, 2022)
Published: June 10, 2022 | Tags: BeiGene, Tislelizumab, NMPA, Approval, Nasopharyngeal Cancer
Published: June 10, 2022 | Tags: Amarin, Vazkepa, icosapent ethyl, NICE, Recommendation, Cardiovascular Disease
Published: June 10, 2022 | Tags: Everest Medicines, Trodelvy, sacituzumab govitecan, NMPA, Approval, Metastatic Triple-Negative Breast Cancer
Published: June 10, 2022 | Tags: AbbVie, P-III, CLL14 Trial, Venclyxto, Venclexta, Chronic Lymphocytic Leukemia, EHA, 2022
Published: June 10, 2022 | Tags: Adverum, ADVM-022, OPTIC Study, Wet, Age-Related Macular Degeneration
Published: June 10, 2022 | Tags: Olema, Aurigene, Cancer, Palbociclib, OP-1250
Published: June 9, 2022 | Tags: STADA , Alvotech, AVT02, biosimilar, adalimumab, Inflammatory Conditions
Published: June 9, 2022 | Tags: Takeda, TAK-003, P-III, TIDES Trial, Dengue, NECTM8, 2022
Published: June 9, 2022 | Tags: Vertex, Inaxaplin, VX-147, US, FDA, Breakthrough Therapy Designation, EMA, PRIME Designation, APOL1-Mediated, FSGS, AMKD
Published: June 9, 2022 | Tags: Abbott, MitraClip, TriClip Device, Heart Failure
Published: June 9, 2022 | Tags: Immunocore, Kimmtrak, tebentafusp, Approval, Uveal Melanoma, UK, Australia, Canada
Published: June 9, 2022 | Tags: AstraZeneca, Evusheld, tixagevimab, cilgavimab, P-III, TACKLE Trial, COVID-19
Published: June 8, 2022 | Tags: Moderna, Bivalent, Booster, mRNA -1273.214, P-II/III Trial, Omicron
Published: June 8, 2022 | Tags: Roche, Lunsumio, mosunetuzumab, EC, Approval, Follicular Lymphoma
Published: June 8, 2022 | Tags: SeaStar Medical, Selective Cytopheretic Device, Pilot SCD 005 Study, COVID-19, SCCM, 2022
Published: June 8, 2022 | Tags: Sanofi, Dupixent, dupilumab, US, FDA, Approval, Atopic Dermatitis
Published: June 8, 2022 | Tags: Merck, Ridgeback, Lagevrio, molnupiravir, P-III, MOVe-OUT Trial, COVID-19
Published: June 8, 2022 | Tags: Novartis, Tafinlar, dabrafenib, Mekinist, trametinib, P-II/III, TADPOLE Trial, BRAF V600, Low-Grade Gliomas, ASCO, 2022
Published: June 7, 2022 | Tags: GSK, Priorix, US, FDA, Approval, Measles, Mumps, Rubella
Published: June 7, 2022 | Tags: Eli Lilly, Lebrikizumab, P-III, ADvocate 1, ADvocate 2 Trial, Atopic Dermatitis
Published: June 7, 2022 | Tags: Abbott, Freestyle Libre 3 System, Type 1, Type 2 Diabetes, ADA, 2022
Published: June 7, 2022 | Tags: Amgen’s Riabni, biosimilar, rituximab, US, FDA, Approval, Rheumatoid Arthritis
Published: June 7, 2022 | Tags: BMS, Opdivo, nivolumab, Yervoy, ipilimumab, P-III, CheckMate -9LA, CheckMate -227 Trial, mNSCLC
Published: June 7, 2022 | Tags: Biogen, Alectos, AL01811, Parkinson’s Disease
Published: June 6, 2022 | Tags: Yumanity, Purchase Agreement, Janssen, YTX-7739, Kineta, KVA12.1
Published: June 6, 2022 | Tags: AstraZeneca, Calquence, acalabrutinib, P-III, ELEVATE-TN Trial, Chronic Lymphocytic Leukaemia, ASCO, 2022
Published: June 6, 2022 | Tags: Insulet, Omnipod 5 Automated Insulin Delivery System, Glycemic Outcomes, Type 1 Diabetes, ADA, 2022
Published: June 6, 2022 | Tags: Biogen, Bio-Thera Solutions, BIIB800, biosimilar, tocilizumab, P-III Trial, Rheumatoid Arthritis, EULAR, 2022
Published: June 6, 2022 | Tags: Merck, Keytruda, pembrolizumab, P-III, KEYNOTE-716 Trial, Resected, Stage IIB, IIC, Melanoma, ASCO, 2022
Published: June 6, 2022 | Tags: Eli Lilly, Tirzepatide, P-III, SURMOUNT-1 Trial, Obesity, Overweight, NEJM
Related Post: PharmaShots Weekly Snapshots (May 30 – June 03, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.